JPRN-UMIN000007413已完成2 期
Phase II Study of Safety and Efficacy. Dasatinib in Patients with Chronic Phase Chronic Myelogenous Leukemia achieving a Major Molecular Response on Imatinib. - Dasatinib CMR-trial
CML stem cell study group0 个研究点目标入组 20 人开始时间: 2012年3月1日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Active double cancer 2)Pregnant or breastfeeding woman 3)Patient who has clear pleural effusion 4)Patient who have the anamnesis or complications of a cardiovascular disorder with serious or poor control. -myocardial infarction within 6 months -angina pectoris within 3 months -congestive heart failure within 3 months -congenital long QT syndrome
研究者
相似试验
进行中（未招募）
1 期
A clinical trial to test the safety, efficacy and plasma concentration of G1T28 in patients with metastatic triple negative breast cancer receiving gemcitabine and carboplatin chemotherapyocally recurrent or metastatic Triple Negative Breast CancerMedDRA version: 20.0Level: PTClassification code 10075566Term: Triple negative breast cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2016-004466-26-BGG1 Therapeutics90
进行中（未招募）
1 期
A clinical trial to test the safety, efficacy and plasma concentration of G1T28 in patients with metastatic triple negative breast cancer receiving gemcitabine and carboplatin chemotherapyEUCTR2016-004466-26-SIG1 Therapeutics90
进行中（未招募）
1 期
A clinical trial to test the safety, efficacy and plasma concentration of G1T28 in patients with metastatic triple negative breast cancer receiving gemcitabine and carboplatin chemotherapyocally recurrent or metastatic Triple Negative Breast CancerMedDRA version: 20.0Level: PTClassification code 10075566Term: Triple negative breast cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2016-004466-26-BEG1 Therapeutics90
进行中（未招募）
1 期
A clinical trial to test the safety, efficacy and plasma concentration of G1T28 in patients with metastatic triple negative breast cancer receiving gemcitabine and carboplatin chemotherapyEUCTR2016-004466-26-HRG1 Therapeutics142
进行中（未招募）
不适用
Evaluation of efficacy and safety of analgesia with transmucosal fentanyl citrate in oncologic patients eligible to permanent central venous catheterEUCTR2012-002469-37-ITCENTRO DI RIFERIMENTO ONCOLOGICO DI AVIANO